Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Coagulation profile in patients undergoing VATS lung cancer surgery with or without dalteparin prophylaxis
2012-002409-23Phase 2Completed
- Sponsor
- Aarhus University Hospital
- Start
- Jul 2012
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised trial of dalteparin in venous thromboembolism (VTE) (2 arms), sponsored by Aarhus University Hospital. Primary endpoints: Coagulability via ROTEM, Thrombin generation and 2 more. Started Jul 2012; status: completed.
02
Drugs
dalteparin
03
Conditions
venous thromboembolism (VTE)
Beyond the preview
Go deeper on 2012-002409-23.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-002409-23.